Form 4 for PCVX Vaxcyte, Inc.
Accepted 2026-09-02 19:58:39 ET · period of report 2026-08-31 · accession 0001813798-26-000017 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-09-02 19:58 | 2026-08-31+ | PCVX | Wassil Jim | COO | F - Tax | $61.18 | -2,705 | 153.6K | -2% | -$165.5K |
| D | 2026-09-02 19:58 | 2026-09-01 | PCVX | Wassil Jim | COO | M - OptEx | $5.35 | +2,250 | 158.5K | +1% | +$12.0K |
| DM | 2026-09-02 19:58 | 2026-09-01 | PCVX | Wassil Jim | COO | S - Sale+OE | $61.07 | -3,477 | 155.0K | -2% | -$212.4K |
| D | 2026-09-02 19:58 | 2026-09-01 | PCVX | Wassil Jim | COO | M - OptEx | $0.00 | -2,250 | 66.6K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-31 | F | D | 1,273 | $60.74 | 156,268 | D | — | — | (F1) Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs. |
| 2 | Common | Common Stock | 2026-09-01 | M | A | 2,250 | $5.35 | 158,518 | D | — | — | |
| 3 | Common | Common Stock | 2026-09-01 | S | D | 1,537 | $60.89 | 156,981 | D | — | — | (F2) The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025. (F3) The price reported is a weighted-average price. The shares were sold at prices ranging from $60.29 to $61.275. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 4 | Common | Common Stock | 2026-09-01 | S | D | 713 | $61.48 | 156,268 | D | — | — | (F2) The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025. (F4) The price reported is a weighted-average price. The shares were sold at prices ranging from $61.31 to $62.04. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 5 | Common | Common Stock | 2026-09-01 | S | D | 924 | $60.95 | 155,344 | D | — | — | (F2) The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025. (F5) The price reported is a weighted-average price. The shares were sold at prices ranging from $60.29 to $61.22. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 6 | Common | Common Stock | 2026-09-01 | S | D | 303 | $61.42 | 155,041 | D | — | — | (F2) The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025. (F6) The price reported is a weighted-average price. The shares were sold at prices ranging from $61.34 to $61.48. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 7 | Common | Common Stock | 2026-09-02 | F | D | 1,432 | $61.58 | 153,609 | D | — | — | (F1) Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs. |
| 8 | Derivative | Stock Option (right to buy) | 2026-09-01 | M | D | 2,250 | $0.00 | 66,648 | D | $5.35 · — to 2030-04-17 | 2,250 Common Stock | (F7) Stock Option is fully vested and exercisable. |